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Background: Aneuploidy is one of the major factors that result in low efficiency in human infertility treatment by
in vitro fertilization (IVF). The development of DNA microarray technology allows for aneuploidy screening by
analyzing all 23 pairs of chromosomes in human embryos. All chromosome screening for aneuploidy is more
accurate than partial chromosome screening, as errors can occur in any chromosome. Currently, chromosome
screening for aneuploidy is performed in developing embryos, mainly blastocysts. It has not been performed in
arrested embryos and/or compared between developing embryos and arrested embryos from the same IVF cycle.
Methods: The present study was designed to examine all chromosomes in blastocysts and arrested embryos from
the same cycle in patients of advanced maternal ages. Embryos were produced by routine IVF procedures. A total
of 90 embryos (45 blastocysts and 45 arrested embryos) from 17 patients were biopsied and analyzed by the
Agilent DNA array platform.
Results: It was found that 50% of the embryos developed to blastocyst stage; however, only 15.6% of the embryos
(both blastocyst and arrested) were euploid, and most (84.4%) of the embryos had chromosomal abnormalities.
Further analysis indicated that 28.9% of blastocysts were euploid and 71.1% were aneuploid. By contrast, only one
(2.2%) arrested embryo was euploid while others (97.8%) were aneuploid. The prevalence of multiple chromosomal
abnormalities in the aneuploid embryos was also higher in the arrested embryos than in the blastocysts.
Conclusions: These results indicate that high proportions of human embryos from patients of advanced maternal
age are aneuploid, and the arrested embryos are more likely to have abnormal chromosomes than developing
embryos.
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Human fertility, especially female fertility, declines dra-
matically in an age-dependent manner, mainly due to
the decline of both quality and quantity of the oocyte
and follicle pool with increasing maternal age [1,2]. The
proportion of oocytes with abnormal chromosomes also
increases with maternal aging, which is a major factor
causing aneuploid formation in the resulting embryos.
Embryonic aneuploidy is also a major cause of failed
embryo implantation and miscarriage; hence aneuploidy* Correspondence: wangweihua11@yahoo.com
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unless otherwise stated.is considered to be one of the most important factors
causing the low efficiency of in vitro fertilization (IVF)
treatments. Due to high rates of aneuploidy in the
embryos from patients of advanced maternal age [3-7],
several strategies have been carried out to select the
euploid embryos for transfer so that the embryo im-
plantation rate can be increased. One of these strategies
is preimplantation genetic screening (PGS) by DNA
microarray, which is able to examine all 23 pairs of chro-
mosomes in the samples biopsied from embryos. It has
been reported that significantly increased clinical preg-
nancy and embryo implantation rates were obtained
after transfer of euploid blastocysts screened by DNA
microarray [2,8,9].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Qi et al. Journal of Ovarian Research 2014, 7:65 Page 2 of 8
http://www.ovarianresearch.com/content/7/1/65Currently, PGS is performed in samples biopsied from
polar bodies [10-13], cleavage embryos [14,15] or blasto-
cysts [16,17]. It has been found that blastocysts have less
mosaicism than cleavage embryos, thus most laboratories
prefer blastocyst biopsy, in which multiple cells from the
trophectoderm (TE) are biopsied and used for screening
[8,9]. It is estimated that approximately 40-70% of human
embryos produced by IVF are able to develop to blastocyst
while others arrest at different earlier stages [18-22]. PGS
is usually performed in the blastocysts, not in the arrested
embryos because the information in the arrested embryos
is of no clinical value. However, for better understanding
of the mechanisms of embryo development and aneuploid
formation, it is necessary to investigate the effects of
chromosome integrity, in addition to embryo quality, on
embryo development.
Previously, when fluorescence in-situ hybridization
(FISH) technology was used for examination of 5-12 chro-
mosomes in human embryos, it was found that a number
of the arrested embryos were euploid [18], but it is still
unknown whether these embryos are truly euploid or not.
It was found that chromosome abnormalities occurred in
any chromosome when embryos were examined by 24
chromosome microarray, and the proportion of abnormal
13, 18, 21, X and Y chromosomes (the most common
chromosomes for FISH analysis) only accounted for 25%
of all abnormities [2,23]. Previous studies also indicated
that embryos screened by FISH technology had lower or
similar implantation rates as compared with non-screened
embryos [5,24,25]. These results indicate that the informa-
tion obtained by FISH technology is not accurate to repre-
sent the chromosomal status of an embryo.
Due to the lack of information on the prevalence of
chromosome abnormities in arrested human embryos, it is
essential to examine all 23 pairs of chromosomes in the
cohort of embryos produced from the same cycle in the
patients so that the data can be compared directly between
developing embryos and arrested embryos. The collected
information would be useful to study the mechanism(s) by
which some human embryos are unable to develop to
blastocyst and arrest at different earlier stages and/or
undergo fragmentation. Therefore, in the present study,
experiments were designed to examine all chromosomes
by DNA microarray in the blastocysts and arrested em-
bryos in patients undergoing IVF and PGS.Methods
Ethics
All patients undergoing IVF and PGS signed written
consents for the laboratory manipulations and tests of
the resulting embryos. This study was approved by
the Institutional Review Board at The Third Hospital
Affiliated to Guangzhou Medical University.Patient preparations for egg retrieval and PGS
Patients received PGS service because they were of
advanced maternal age and needed aneuploidy screening
of their embryos before transfer. For oocyte collection,
patients were treated with a mixed protocol of human
menopausal gonadotropin and a GnRH antagonist. The
follicle stimulation hormone products (Follistim, Gonal-F,
or Bravelle plus Menopure) were usually initiated within
the first 2-3 days after the period began with a starting
dose between 150 and 375 iu per day. The dose was ad-
justed as the stimulation progressed. Human chorionic
gonadotropin (hCG) was injected at a dose of 5000-10000
units to induce final oocyte maturation when at least two
dominant follicles reached a diameter of 18 mm. Eggs
were retrieved via transvaginal ultrasound between 35–37
hours after hCG administration.
Fertilization, embryo culture and embryo biopsy
Oocytes were cultured for 4-5 hours and the surroun-
ding cumulus cells were removed in a HEPES-buffered
medium containing 40 iu hyaluronidase, and the mature
(metaphase II) oocytes were inseminated by intracyto-
plasmic sperm injection (ICSI). Fertilization was exa-
mined 16-18 hours after ICSI, and zygotes were cultured
in a Global medium (IVFonline.com) supplemented with
10% serum protein substitute (SPS, IVFonline) at 37°C
in a humidified atmosphere of 5.5% CO2, 5% O2 and
balanced nitrogen until day 6 after insemination. On day
3, a hole of about 20 μm was opened on the zona pellu-
cida with a laser generated by a ZILOS-tk laser system
(Hamilton Thorne Bioscience Inc., NJ USA). On day 5,
embryos were checked to see if a blastocyst had formed
and if cells began to hatch from the opening in the zona
pellucida. If some cells started to hatch, approximately
three to five TE cells were biopsied using a 20-μm
polished biopsy pipette with assisted cutting by laser.
Blastocyst biopsy was performed on TE cells on day 5
or 6 depending on blastocyst development rate. The
embryos that did not develop to blastocyst on day 6
were considered arrested, and up to five blastomeres
were biopsied from these embryos. The biopsied cells
were washed with a washing buffer, placed in tubes with
cell lysis buffer and then frozen before being processed
for microarray.
Microarray with Agilent DNA array platform
The Agilent array platform was used to examine the chro-
mosomes in the samples. The application of the Agilent
DNA microarray platform in human embryos has been
validated in the previous study, and the results were com-
parable to those obtained with other DNA microarray
platforms, including the most common BluGnome plat-
form [26,27]. Briefly, amplified samples were labeled with
Cy3 using a SureTag DNA labeling kit. Labeled samples
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labeled samples and controls were purified with a SureTag
DNA labeling purification column, dried, dissolved in
hybridization buffer containing Cot-1 DNA, 10 × blocking
agent, and 2 ×HI-RPM hybridization buffer, and loaded
onto a SurePrint G3 60 K Oligo Microarray. After over-
night hybridization at 65°C, microarrays were washed
following Agilent washing protocol. Microarrays were
scanned with a SureScan Microarray Scanner at 3 μM.
Scanned images were analyzed by Cytogenomics software
following Agilent comparative genomic hybridization
(CGH) data analysis protocol.
Statistical analysis
The data were analyzed by ANOVA and differences bet-
ween groups were analyzed by chi-square test. P < 0.05
was considered statistically significant.
Results
High proportions of human embryos were aneuploid and
the aneuploid rate increased with maternal age
A total of 90 embryos from 17 patients were analyzed after
biopsy and microarray. As shown in Table 1, 14 (15.6%)
embryos were euploid with normal 23 pairs of chromo-
somes, and 76 embryos (84.4%) were either aneuploid with
single or multiple chromosome abnormalities, or euploid
with chromosomal deletion or duplication (Figure 1). We
categorized these patients into two groups based on their
maternal ages (36-39 and 40-45 years old). As shown in
Table 1, the aneuploid rate (93.3%) in the patients aged 40
to 45 years was significantly (P <0.05) higher than that in
the patients aged 36 to 39 years (75.6%).
No significant difference was found in the developmental
potential of embryos between younger patients and
older patients
During IVF, approximately 50% of zygotes are able to
develop to blastocysts while others (~50%) may arrest be-
fore blastocyst stage. When we analyzed the relationshipTable 1 Microarray analysis of human embryos
Observation 36
No. of cases 8
Total number of embryos biopsied and examined 45
No. (%)* of embryos with normal chromosomes 11
No. (%)* of embryos with abnormal chromosomes 34
No. (%)** of developing embryos (blastocysts) 25
No. (%)** of arrested embryos 20
*Percentages of embryos with normal (euploid) or abnormal (aneuploidy) chromoso
**Percentages of embryos developed to blastocyst stage or arrested at earlier stage
abP <0.05 within the same row.between the developmental potential of embryos and ma-
ternal age, we found that the blastocyst rate (55.6%) was
higher for the patients aged 36-39 years old than that of
patients aged 40-45 years old (44.4%) (Table 1) but the dif-
ference was not statistically significant (P > 0.05, Table 1).More euploid embryos can develop to blastocysts than
aneuploid embryos
When the relationship between the developmental poten-
tial of embryos and their chromosome integrity was exa-
mined, it was found that 92.9% of the euploid embryos
developed to blastocysts, while only 42.1% of the aneu-
ploid embryos developed to blastocysts (Figure 2), which
was significantly (P <0.01) lower than that from euploid
embryos. This suggests that aneuploidy could significantly
decrease the developmental potential of embryos.Arrested embryos are more likely to have abnormal
chromosomes than developing embryos
As aneuploidy significantly influences embryo develop-
ment, we predicted that more arrested embryos would be
aneuploid. Indeed, as shown in Figure 3, we found that 44
out of 45 arrested embryos (97.8%) were aneuploid, which
was significantly (P <0.01) higher than the rate (71.1%) in
the developing embryos (blastocysts) (Figure 3), indicating
that arrested embryos are more likely to have abnormal
chromosomes than developing embryos.
When we further examined the chromosome distri-
bution and the types of aneuploidies in the aneuploid
embryos, as shown in Figure 4, we did not find significant
differences in the chromosomal distribution between
blastocysts and arrested embryos in terms of monosomy
(25 vs 18.2%) and trisomy (21.9 vs 9.1%). However, more
arrested embryos had multiple chromosomal abnorma-
lities (complex: 72.3%) than blastocysts (53.1%). Errors
occurred randomly in chromosomes, and there was
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Figure 1 (See legend on next page.)
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Figure 1 PGS charts of human embryo samples with different types of chromosome abnormalities analyzed by the Agilent DNA array
platform. (A) An arrested embryo had euploid cells with partial chromosome deletion (46, XX, Del 1p). (B) An arrested embryo had multiple
(47, XX, +11, +15, -16) chromosome errors. (C) An arrested embryo had multiple (44, XY, -21, -22) chromosome errors. (D) A blastocyst had
multiple chromosomal abnormalities. Arrows indicate chromosome errors.
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In the present study, we examined all 23 pairs of chro-
mosomes in both blastocysts and arrested embryos from
the same cycle in patients undergoing IVF and PGS by
DNA microarray. The results indicate that almost all
arrested embryos are aneuploid and the occurrence of
aneuploidy in the blastocysts is closely related with
maternal age.
It is well known that advanced maternal age is corre-
lated with higher rates of embryonic aneuploidy [3-7]. In
the present study, we found that a high proportion
(84.4% in all embryos and 71.1% in blastocysts) of hu-
man embryos from patients of advanced maternal age
was aneuploid, and the rates increased with maternal
age. These results were consistent with those reported
previously by others [2,3,5,7,8,22,23,28]. However, the
aneuploid rate observed in the present study was higher
than those reported in the previous studies [2,3,22,23].
One of the reasons for this high aneuploid rate in the
arrested embryos may be due to the small sample size
observed in the present study; thus the data may not
represent larger populations of IVF patients. Another
reason may be due to the embryo quality and patient
population. The arrested embryos in the present study
stopped development on day 3, but the biopsy and DNA
array test were performed on day 6. Thus, the prolonged
culture may have caused DNA degeneration or damages;
this may also be an explanation of why more arrested
embryos had multiple (complex) chromosomal abnor-
malities than blastocysts. Patient ages may be the major
factor causing aneuploid formation in the present study.
In a previous study with patients aged 37-46 years old, itFigure 2 The development of aneuploid and euploid embryos.
The rates of blastocysts and arrested embryos in aneuploid and
euploid embryos were calculated respectively. Blastocysts were
examined on day 5 and day 6 after fertilization, and chromosomes
were examined by DNA microarray. abP < 0.01.was found that 55-80% of embryos were aneuploid when
FISH probes were used [3]. We had a similar patient
population in this study, but the aneuploid rate was
higher than the results reported previously [3]. We
examined all chromosomes but only 7 chromosomes
were examined in the previous study [3]. Based on our
previous study, chromosomal anomalies could occur in
any chromosome, and the proportions of anomalies in
the most common 5 chromosomes (13, 18, 21, X and Y)
accounted for only 25% of total abnormal chromosomes.
High aneuploid rates in human blastocysts were also re-
ported in a recent study with 15,169 samples, in which
the authors found that all samples could be aneuploid in
30-55% of the patients of advanced maternal age (42-45
years old) [28]. Taking into account these results, the
high aneuploid rate observed in the present study should
be related to the patients’ ages and embryo quality.
Aneuploidy could lead to reduced implantation and
high miscarriage rates, but little is known about its me-
chanisms. Embryos usually arrest at various developmen-
tal stages for various reasons, such as culture conditions,
patients’ ages and ovarian stimulation protocols. However,
it is not known whether aneuploidy can directly influence
embryo development. In the present study, we compared
chromosome errors in the blastocysts and arrested em-
bryos at various earlier stages and it was found that more
euploid embryos developed to blastocyst than aneuploid
embryos. These results indicate that aneuploidy can affect
embryo development. We also found that not only more
arrested embryos were aneuploid, but also more chromo-
somes had errors in the arrested embryos than in blasto-
cysts. These results may explain the reasons that women
of advanced age have lower embryo implantation rates,Figure 3 The proportions of aneuploidy in the developing
embryos and arrested embryos. Embryo stages were examined
on day 5 and day 6 after fertilization, and chromosomes were
examined by DNA microarray. abP < 0.01.
Figure 4 Microarray results of abnormal chromosomes in blastocysts and arrested embryos. (A) Abnormal chromosome distribution in
the blastocysts and arrested embryos. Anomalies include monosomy, trisomy and complex (multiple) chromosome errors. (B) Distribution of
chromosomal errors in the blastocysts. (C) Distribution of chromosome errors in the arrested embryos. abp < 0.05.
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pared to younger women.
Because maternal age increases the risk of aneuploidy,
aneuploidy in turn affects implantation and causes miscar-
riage, PGS can be used to select embryos with normal
chromosomes for transfer to improve implantation and
pregnancy rates. However, previous FISH-based PGS did
not increase the implantation and pregnancy rates due to
its technical limitations (partial chromosome screening)
[5,23-25]. DNA microarray technology has now replaced
the FISH technology, as it can be used to examine all 23
pairs of chromosomes. It has been reported that transfer
of euploid embryos screened by DNA microarray based
PGS can significantly increase clinical pregnancy and em-
bryo implantation rates [2,8,9]. The data obtained in the
present study and previous studies clearly indicate that
aneuploidy exists extensively in human embryos from pa-
tients of advanced maternal age, and PGS by DNA micro-
array is strongly recommended for these patients.It was believed that the quality of embryos from youn-
ger patients may be better than those from older pa-
tients, so we assumed that the development rate of
embryos from patients of advanced maternal age may be
lower than that of younger patients. In the present study,
we found that the blastocyst development rate was
slightly higher in the younger patients than in the older
patients. However, our data did not show a statistical dif-
ference between the two groups. This may be due to the
patient population and small sample size in the present
study. The data were mainly collected from older pa-
tients aged more than 37 years old in the present study.
This population of patients is usually considered as the
patients of advanced maternal age. Thus the younger pa-
tients in the present study may not represent the typical
population of younger patients (less than 35 years old)
undergoing IVF. Furthermore, the small sample size
used in the present study may mask the differences, if
such differences exist. Therefore, further studies with
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cessary for a clearer conclusion to be drawn. Currently,
most clinics also offer blastocyst transfer to patients of
advanced maternal age, but reduced embryo implantation
still exists in these patients, indicating that aneuploidy
could be the main reason affecting embryo implantation
after transfer.
Many studies have been conducted in an effort to reveal
the mechanisms of aneuploid origination in embryos from
patients of advanced maternal age. It has been reported
that maternal aging can dramatically influence the meiotic
spindle assembly process in mammals [29-34], leading to
spindle disorganization and chromosome segregation er-
rors, which in turn cause aneuploid formation. In
addition, the deterioration of sister chromatid cohesion
[35-40] and failure of the spindle assembly checkpoint
[41-44] in the oocytes are also crucial reasons for aneu-
ploid formation.
Conclusions
In conclusion, our present results demonstrate that high
proportions of human embryos from patients of advanced
maternal age are aneuploid, and the arrested embryos are
more likely to have abnormal chromosomes than develop-
ing embryos. Most arrested embryos have multiple chro-
mosome anomalies, indicating that the factors causing
aneuploidy may also affect embryo development, but the
detailed relationship between embryo development and
aneuploidy needs further investigation.
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